Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy

Figure 3

Distribution of TIL in esophageal cancer and various SII populations. (a) The percentage of patients with different concentrations of TIL. (b) The distribution of TIL in the whole, low, and high SII populations. SII, systemic immune-inflammation index; TIL, tumor-infiltrating lymphocytes.

(a)

(b)